Get the Stockscreener App
88.67
0.80%
-0.67
Dexcom Inc stock is traded at $88.67, with a volume of 326.20K.
It is down -0.80% in the last 24 hours and up +2.67% over the past month.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
See More
Previous Close:
$89.34
Open:
$88.6
24h Volume:
326.20K
Relative Volume:
0.10
Market Cap:
$35.80B
Revenue:
$4.03B
Net Income/Loss:
$576.20M
P/E Ratio:
62.01
EPS:
1.43
Net Cash Flow:
$630.70M
1W Performance:
-0.50%
1M Performance:
+2.67%
6M Performance:
+21.08%
1Y Performance:
-23.85%
1-Day Range:
$87.56
$89.17
1-Week Range:
$87.56
$93.25
52-Week Range:
$62.34
$142.00
Dexcom Inc Stock (DXCM) Company Profile
Name
Dexcom Inc
Sector
Industry
Phone
(858) 200-0200
Address
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Compare DXCM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
88.65 | 35.80B | 4.03B | 576.20M | 630.70M | 1.43 |
|
ABT
Abbott Laboratories
|
134.38 | 230.98B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.43 | 155.49B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
386.55 | 147.45B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.82 | 112.85B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
74.12 | 44.06B | 5.72B | 4.17B | 490.10M | 6.97 |
Dexcom Inc Stock (DXCM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-03-25 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Jan-16-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jul-26-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-26-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-30-24 | Initiated | Redburn Atlantic | Neutral |
| Mar-12-24 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-17-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Mar-29-23 | Initiated | UBS | Buy |
| Jan-26-23 | Initiated | Wolfe Research | Outperform |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-15-22 | Initiated | Bernstein | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-03-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-19-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-07-22 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-18-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-28-21 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Jan-06-21 | Upgrade | UBS | Neutral → Buy |
| Oct-02-20 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| May-27-20 | Reiterated | Piper Sandler | Overweight |
| May-14-20 | Initiated | Wells Fargo | Equal Weight |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Nov-07-19 | Reiterated | Canaccord Genuity | Buy |
| Nov-07-19 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-23-19 | Initiated | Stifel | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Oct-19-18 | Upgrade | Goldman | Sell → Neutral |
| Sep-12-18 | Upgrade | Northland Capital | Under Perform → Market Perform |
| Aug-02-18 | Reiterated | Canaccord Genuity | Buy |
| Jul-02-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-08-18 | Upgrade | JP Morgan | Neutral → Overweight |
| May-11-18 | Initiated | BofA/Merrill | Buy |
| May-03-18 | Reiterated | Canaccord Genuity | Buy |
| Apr-04-18 | Initiated | Goldman | Sell |
| Apr-04-18 | Initiated | Guggenheim | Neutral |
| Mar-23-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-04-18 | Downgrade | Northland Capital | Market Perform → Under Perform |
| Sep-28-17 | Reiterated | Wedbush | Outperform |
View All
Dexcom Inc Stock (DXCM) Latest News
Glucose Biosensor Market to Witness Remarkable Growth with Abbott Laboratories, Dexcom, F. Hoffmann-La Roche - EIN News
Earnings Miss: DexCom, Inc. Missed EPS By 7.8% And Analysts Are Revising Their Forecasts - Simply Wall St
Ownership Capital B.V. Decreases Stake in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Principal Financial Group Inc. Decreases Stake in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Peregrine Capital Management LLC Sells 29,135 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Lost Money on DexCom, Inc.(DXCM)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - ACCESS Newswire
Alberta Investment Management Corp Acquires 36,500 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Lyell Wealth Management LP Has $4.71 Million Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Congress Asset Management Co. Increases Stake in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Shares Sold by GAM Holding AG - MarketBeat
Kornitzer Capital Management Inc. KS Has $4.34 Million Stock Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Chevy Chase Trust Holdings LLC Sells 9,886 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Leerink Partnrs Has Bullish Forecast for DexCom Q1 Earnings - MarketBeat
Morgan Stanley Issues Positive Forecast for DexCom (NASDAQ:DXCM) Stock Price - MarketBeat
Is DexCom, Inc. (DXCM) the Best IoT Stock to Buy According to Analysts? - Insider Monkey
Cardinal Capital Management Invests $3.46 Million in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Van ECK Associates Corp Increases Stock Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Banque Pictet & Cie SA Acquires 14,419 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Kestra Private Wealth Services LLC Grows Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Position Lessened by Compagnie Lombard Odier SCmA - MarketBeat
DexCom (NASDAQ:DXCM) Posts Quarterly Earnings Results, Misses Expectations By $0.05 EPS - MarketBeat
DexCom's SWOT analysis: stock faces challenges amid growth potential - Investing.com India
Baillie Gifford & Co. Has $1.14 Billion Stock Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Rhumbline Advisers Reduces Stake in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Vontobel Holding Ltd. Trims Stock Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Louisiana State Employees Retirement System Sells 3,700 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Canaccord Genuity Group Forecasts Strong Price Appreciation for DexCom (NASDAQ:DXCM) Stock - MarketBeat
Empire Life Investments Inc. Raises Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
New York State Teachers Retirement System Cuts Stock Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Asset Management One Co. Ltd. Has $19.53 Million Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Q4 2024 Earnings Call Transcript - MSN
DexCom Stock Outlook: Is Wall Street Bullish or Bearish? - MSN
3,145 Shares in DexCom, Inc. (NASDAQ:DXCM) Acquired by Angeles Wealth Management LLC - MarketBeat
Equitable Trust Co. Has $925,000 Stock Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Savant Capital LLC Has $8.58 Million Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
DexCom’s Optimistic Earnings Call: Growth Amid Challenges - TipRanks
DexCom Inc. stock outperforms competitors on strong trading day - MSN
DexCom (NASDAQ:DXCM) Stock Quotes, Forecast and News Summary - Benzinga
DexCom, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More InformationDXCM - ACCESS Newswire
Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom - Benzinga
Meta Platforms, Dexcom, Dell - TradingView
DexCom Unusual Options Activity - Benzinga
DexCom, Inc.'s (NASDAQ:DXCM) Intrinsic Value Is Potentially 38% Above Its Share Price - Simply Wall St
DexCom stock target raised to $100 by Bernstein analysts - Investing.com Nigeria
DexCom Likely to Sustain Stability in 2025, Morgan Stanley Says -February 14, 2025 at 12:12 pm EST - Marketscreener.com
DexCom Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart
DexCom Analysts Increase Their Forecasts After Q4 Earnings - Benzinga
Piper Sandler Adjusts Price Target on DexCom to $100 From $90 -February 14, 2025 at 08:45 am EST - Marketscreener.com
Wells Fargo Adjusts Price Target on DexCom to $98 From $94 -February 14, 2025 at 08:45 am EST - Marketscreener.com
Citigroup Adjusts Price Target on DexCom to $101 From $91 -February 14, 2025 at 08:37 am EST - Marketscreener.com
Bernstein Adjusts Price Target on DexCom to $100 From $89 -February 14, 2025 at 08:33 am EST - Marketscreener.com
Dexcom Inc Stock (DXCM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.89%
0.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):